What was the primary driver behind the significant decrease in net income compared to the prior year?

The primary driver for the substantial decrease in net income from $115.0 million in Q1 2002 to $36.4 million in Q1 2003 was a significant reduction in 'Other Income, Net.' Specifically, gains on the sale of investments, particularly from FLIR Systems, Inc., were considerably lower in the current quarter ($5.2 million) compared to the prior year ($58.0 million).

How has the company managed its debt levels during the quarter?

Thermo Fisher Scientific significantly reduced its financial obligations. Short-term obligations and current maturities of long-term obligations decreased by nearly half, from $484.5 million at year-end 2002 to $246.1 million at the end of the first quarter of 2003. Additionally, long-term obligations decreased by approximately $15.5 million.

What is the company's outlook for the coming quarters, considering the current economic environment?

Management acknowledges the general worldwide economic slowdown and related uncertainties, which are impacting its markets. While the company believes its existing resources are sufficient for foreseeable future needs, it notes that continued softness in key markets like laboratory equipment, industrial manufacturing, and semiconductors could adversely affect future operating results. The company expects continued restructuring efforts through 2003.

What are the implications of the adoption of EITF No. 00-21 on the financial results?

Thermo Fisher early adopted EITF No. 00-21, 'Accounting for Revenue Arrangements with Multiple Deliverables,' prospectively starting in Q1 2003. This change in accounting policy resulted in an increase in revenues of $7.6 million and a $0.01 increase in diluted earnings per share for the first quarter of 2003, by recognizing revenue as deliverables are completed based on their fair value rather than deferring all revenue until installation was complete.

TMO 10-Q Quarterly Report Q1 FY2003 — Revenue, Net Income, EPS

Summary

Thermo Fisher Scientific Inc. (TMO) reported its first quarter 2003 financial results, showing a modest increase in revenue to $500.2 million, up 2% from the prior year. However, net income significantly decreased to $36.4 million from $115.0 million in the same period last year. This decline was largely driven by a substantial decrease in "Other Income, Net," which included significantly lower gains from investment sales compared to the prior year. Despite the profit drop, the company demonstrated a commitment to deleveraging, significantly reducing its short-term obligations and long-term debt, evidenced by a substantial decrease in current liabilities and long-term obligations compared to the previous year-end. The company also continued its share repurchase program. Management indicated that while current resources are sufficient, the company is navigating economic slowdowns impacting its key markets.

Key Highlights

1Revenue increased by 2% to $500.2 million for the first quarter of 2003, compared to $491.3 million in the prior year.
2Net income decreased significantly to $36.4 million from $115.0 million in the first quarter of 2002, primarily due to lower investment gains.
3Earnings per diluted share from continuing operations were $0.19, down from $0.34 in the prior year.
4The company significantly reduced its short-term obligations and current maturities of long-term obligations by approximately 47% to $246.1 million from $484.5 million.
5Cash and cash equivalents decreased to $249.1 million from $339.0 million, reflecting operating and financing activities.
6Restructuring charges were reported across multiple segments, with ongoing actions expected to continue through 2003.
7The company early adopted EITF No. 00-21 for revenue recognition on multiple-deliverable arrangements, which slightly increased revenue and EPS in the quarter.

THERMO FISHER SCIENTIFIC INC. Quarterly Report for Q1 Ended Mar 29, 2003

Summary

Key Highlights

Frequently Asked Questions